Back to Authors

Geda, Yonas E.

https://orcid.org/0000-0003-1187-7230

A5058106909 | I1324766304

Mayo Clinic

for the DIAGNOSE CTE Research Project

Citations 226

P1‐131: Excessive daytime sleepiness is comparable in behavioral variant frontotemporal dementia and Alzheimer's disease dementia but greater in dementia with lewy bodies

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_8 | Pages: No page available

10.1016/j.jalz.2015.06.329

IC‐P‐151: Longitudinal outcomes and profiles of distinct biomarker clusters based on vascular disease, neurodegeneration, and amyloid deposition

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_2 | Pages: No page available

10.1016/j.jalz.2015.06.174

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

JAMA Neurology | November 23, 2015 | Volume: 73 | Issue: 1 | Pages: 85

10.1001/jamaneurol.2015.3098 | PMID 26595683

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

JAMA Neurology | November 16, 2015 | Volume: 73 | Issue: 1 | Pages: 93

10.1001/jamaneurol.2015.2952 | PMID 26569387

Multimorbidity and Risk of Mild Cognitive Impairment

Journal of the American Geriatrics Society | August 27, 2015 | Volume: 63 | Issue: 9 | Pages: 1783-1790

10.1111/jgs.13612 | PMID 26311270

Objectives To determine the association between multiple chronic conditions and risk of incident mild cognitive impairment ( MCI ) and dementia. Design Prospective cohort study. Setting Olmsted County, Minnesota. Participants Cognitively normal individuals (N = 2,176) enrolled in the Mayo Clinic Study of Aging ( MCSA ). Measurements Participants were randomly selected from the community, evaluated by a physician, and underwent neuropsychometric testing at baseline and at 15‐month intervals to assess diagnoses of MCI and dementia. Information on International Classification of Diseases, Ninth Revision codes for chronic conditions in the 5 years before enrollment was electronically captured using the Rochester Epidemiology Project medical records linkage system. Multimorbidity was defined as having two or more chronic conditions, and the association between multimorbidity and MCI and dementia was examined using Cox proportional hazards models. Results Of 2,176 cognitively normal participants (mean age ± standard deviation 78.5 ± 5.2; 50.6% male), 1,884 (86.6%) had multimorbidity. The risk of MCI or dementia was higher in persons with multimorbidity (hazard ratio ( HR ) = 1.38, 95% confidence interval ( CI ) = 1.05–1.82) than in those with one or no chronic condition. The HR was of greater magnitude in persons with four or more conditions ( HR = 1.61, 95% CI = 1.21–2.13) than in those with two or three conditions ( HR = 1.03, 95% CI = 0.76–1.39) and for men with multimorbidity( HR = 1.53, 95% CI = 1.01–2.31) than for women with multimorbidity ( HR = 1.20, 95% CI = 0.83–1.74), compared to those with one or no chronic condition. Conclusion In older adults, having multiple chronic conditions is associated with greater risk of MCI and dementia. This is consistent with the hypothesis that multiple etiologies may contribute to MCI and late‐life dementia. Preventing chronic diseases may be beneficial in delaying or preventing MCI and dementia.
Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment

Alzheimer's & Dementia | June 18, 2015 | Volume: 12 | Issue: 2 | Pages: 195-202

10.1016/j.jalz.2015.05.017 | PMID 26096665

Abstract Neuropsychiatric symptoms (NPS) are common in dementia and in predementia syndromes such as mild cognitive impairment (MCI). NPS in MCI confer a greater risk for conversion to dementia in comparison to MCI patients without NPS. NPS in older adults with normal cognition also confers a greater risk of cognitive decline in comparison to older adults without NPS. Mild behavioral impairment (MBI) has been proposed as a diagnostic construct aimed to identify patients with an increased risk of developing dementia, but who may or may not have cognitive symptoms. We propose criteria that include MCI in the MBI framework, in contrast to prior definitions of MBI. Although MBI and MCI can co‐occur, we suggest that they are different and that both portend a higher risk of dementia. These MBI criteria extend the previous literature in this area and will serve as a template for validation of the MBI construct from epidemiologic, neurobiological, treatment, and prevention perspectives.
Risk and protective factors for cognitive impairment in persons aged 85 years and older

Neurology | April 9, 2015 | Volume: 84 | Issue: 18 | Pages: 1854-1861

10.1212/wnl.0000000000001537 | PMID 25854867

APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons

The Journal of Neuropsychiatry and Clinical Neurosciences | March 24, 2015 | Volume: 27 | Issue: 4 | Pages: 322-325

10.1176/appi.neuropsych.14100268 | PMID 25803305

Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging

Neurology | March 18, 2015 | Volume: 84 | Issue: 14 | Pages: 1433-1442

10.1212/wnl.0000000000001437 | PMID 25788555

Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia

Neurology | February 5, 2015 | Volume: 84 | Issue: 9 | Pages: 935-943

10.1212/wnl.0000000000001307 | PMID 25653291